1. Home
  2. XOMA vs SOPH Comparison

XOMA vs SOPH Comparison

Compare XOMA & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • SOPH
  • Stock Information
  • Founded
  • XOMA 1981
  • SOPH 2011
  • Country
  • XOMA United States
  • SOPH Switzerland
  • Employees
  • XOMA N/A
  • SOPH N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • SOPH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • XOMA Health Care
  • SOPH Health Care
  • Exchange
  • XOMA Nasdaq
  • SOPH Nasdaq
  • Market Cap
  • XOMA 330.2M
  • SOPH 219.8M
  • IPO Year
  • XOMA N/A
  • SOPH 2021
  • Fundamental
  • Price
  • XOMA $27.64
  • SOPH $3.62
  • Analyst Decision
  • XOMA Strong Buy
  • SOPH Buy
  • Analyst Count
  • XOMA 2
  • SOPH 1
  • Target Price
  • XOMA $69.50
  • SOPH $7.00
  • AVG Volume (30 Days)
  • XOMA 86.1K
  • SOPH 168.0K
  • Earning Date
  • XOMA 08-12-2025
  • SOPH 08-05-2025
  • Dividend Yield
  • XOMA N/A
  • SOPH N/A
  • EPS Growth
  • XOMA N/A
  • SOPH N/A
  • EPS
  • XOMA N/A
  • SOPH N/A
  • Revenue
  • XOMA $42,909,000.00
  • SOPH $67,173,000.00
  • Revenue This Year
  • XOMA $70.91
  • SOPH $16.07
  • Revenue Next Year
  • XOMA $14.00
  • SOPH $22.94
  • P/E Ratio
  • XOMA N/A
  • SOPH N/A
  • Revenue Growth
  • XOMA 638.41
  • SOPH 4.66
  • 52 Week Low
  • XOMA $18.35
  • SOPH $2.58
  • 52 Week High
  • XOMA $35.00
  • SOPH $4.92
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 59.23
  • SOPH 70.98
  • Support Level
  • XOMA $26.10
  • SOPH $2.81
  • Resistance Level
  • XOMA $28.70
  • SOPH $3.40
  • Average True Range (ATR)
  • XOMA 1.38
  • SOPH 0.30
  • MACD
  • XOMA 0.13
  • SOPH 0.07
  • Stochastic Oscillator
  • XOMA 79.17
  • SOPH 98.31

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Share on Social Networks: